Trump's steadfast backing of Robert F. Kennedy Jr. for Health and Human Services Secretary, combined with Republican control of the Senate following the 2024 elections, anchors the 74.5% implied probability on "No" for RFK Jr. exiting by December 31. His December confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee drew sharp questions on vaccines and chronic disease policies, yet lacked disqualifying revelations, with several GOP senators expressing support. No withdrawal signals have emerged amid the administration transition, and traders anticipate committee advancement soon, reflecting crowd wisdom on sustained nomination viability despite Democratic opposition and lingering scrutiny over his public health views. Upcoming full Senate votes add uncertainty, but historical lame-duck confirmations favor continuity.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
マーケット開始日: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Trump's steadfast backing of Robert F. Kennedy Jr. for Health and Human Services Secretary, combined with Republican control of the Senate following the 2024 elections, anchors the 74.5% implied probability on "No" for RFK Jr. exiting by December 31. His December confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee drew sharp questions on vaccines and chronic disease policies, yet lacked disqualifying revelations, with several GOP senators expressing support. No withdrawal signals have emerged amid the administration transition, and traders anticipate committee advancement soon, reflecting crowd wisdom on sustained nomination viability despite Democratic opposition and lingering scrutiny over his public health views. Upcoming full Senate votes add uncertainty, but historical lame-duck confirmations favor continuity.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問